239 related articles for article (PubMed ID: 20367530)
21. Micro- and nanocarrier-mediated lung targeting.
Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
[TBL] [Abstract][Full Text] [Related]
22. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function.
Hirakura T; Yasugi K; Nemoto T; Sato M; Shimoboji T; Aso Y; Morimoto N; Akiyoshi K
J Control Release; 2010 Mar; 142(3):483-9. PubMed ID: 19951730
[TBL] [Abstract][Full Text] [Related]
23. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
Cadete A; Alonso MJ
Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
[TBL] [Abstract][Full Text] [Related]
24. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
Danhier F; Feron O; Préat V
J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
[TBL] [Abstract][Full Text] [Related]
25. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition.
Mok H; Park JW; Park TG
Bioconjug Chem; 2007; 18(5):1483-9. PubMed ID: 17602578
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.
Wickens JM; Alsaab HO; Kesharwani P; Bhise K; Amin MCIM; Tekade RK; Gupta U; Iyer AK
Drug Discov Today; 2017 Apr; 22(4):665-680. PubMed ID: 28017836
[TBL] [Abstract][Full Text] [Related]
28. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
Juillerat-Jeanneret L; Schmitt F
Med Res Rev; 2007 Jul; 27(4):574-90. PubMed ID: 17022028
[TBL] [Abstract][Full Text] [Related]
29. Delivery of anticancer drugs.
Zee-Cheng RK; Cheng CC
Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
[TBL] [Abstract][Full Text] [Related]
30. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570
[TBL] [Abstract][Full Text] [Related]
31. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
[TBL] [Abstract][Full Text] [Related]
32. Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots.
Kim KS; Hur W; Park SJ; Hong SW; Choi JE; Goh EJ; Yoon SK; Hahn SK
ACS Nano; 2010 Jun; 4(6):3005-14. PubMed ID: 20518553
[TBL] [Abstract][Full Text] [Related]
33. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid-based conjugates for tumor-targeted drug delivery and imaging.
Saravanakumar G; Deepagan VG; Jayakumar R; Park JH
J Biomed Nanotechnol; 2014 Jan; 10(1):17-31. PubMed ID: 24724496
[TBL] [Abstract][Full Text] [Related]
35. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
37. Advances in Hyaluronic Acid-Based Drug Delivery Systems.
Jiao Y; Pang X; Zhai G
Curr Drug Targets; 2016; 17(6):720-30. PubMed ID: 26028046
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity.
Lee H; Lee K; Park TG
Bioconjug Chem; 2008 Jun; 19(6):1319-25. PubMed ID: 18481885
[TBL] [Abstract][Full Text] [Related]
39. Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug.
Pitarresi G; Palumbo FS; Albanese A; Fiorica C; Picone P; Giammona G
J Drug Target; 2010 May; 18(4):264-76. PubMed ID: 19939202
[TBL] [Abstract][Full Text] [Related]
40. Nanostructure-mediated drug delivery.
Hughes GA
Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]